Head-to-head · Cost-Efficiency Index
Gala Health vs MyFastRx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Gala Health
Women who have already committed to a full year and want one all-doses-included rate — plus, unusually, an HRT and menopause line running on the same account as the weight program.
Visit Gala HealthMyFastRx
Cost-first shoppers who want cash-pay shoppers comfortable prepaying several months upfront to reach the lowest per-month compounded-GLP-1 rate on the market.
Visit MyFastRxThe verdict
MyFastRx takes it, leading the Cost-Efficiency Index 73 to 71. MyFastRx is a cash-pay compounded-GLP-1 platform with a full published price ladder: a $139/mo semaglutide and $199/mo tirzepatide standing month-to-month rate, a discounted first month with a promo code. Gala Health still earns a C — Women who have already committed to a full year and want one all-doses-included rate — plus, unusually, an HRT and menopause line running on the same account as the weight program.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs MyFastRx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Gala Health | MyFastRx |
|---|---|---|
| Cost-Efficiency Index | 71/100 | 73/100 |
| Semaglutide / mo | No compounded option — brand Ozempic only, $1,299/mo | $139/mo (all doses, promotional rate, compounded) |
| Tirzepatide / mo | $179/mo (yearly subscription; $199/mo on a 3-month plan) | $199/mo (all doses, promotional rate, compounded) |
| Semaglutide / yr (modeled) | — | $1,668 |
| Tirzepatide / yr (modeled) | $2,148 | $2,388 |
| Coverage | 50 states claimed, no list published | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #63 | #68 |
Gala Health
71/100Where the value is
- $179/mo on a yearly subscription, with every dose included, so the price does not climb as you titrate — dose escalation is where most flat-looking programs quietly get expensive
- The price list is PUBLIC and un-gated: the weight tier, the $149 microdosing tier and the brand tier are all printed before any quiz, intake or email capture
- Both compounded molecules — semaglutide and tirzepatide — prescribable on one account
The tradeoffs
- No month-to-month price exists anywhere on the site. "FROM $179/month" sits directly above "All doses included. Yearly subscription.", and the cheapest alternative the FAQ names is "$199 per month (with a 3-month plan)" — three months is the shortest published commitment there is
- $179/mo is $2,148 committed for the year, and that total is printed nowhere: the site quotes a monthly figure for a purchase it only sells annually, which is the single hardest cost in this ranking to compare against a rate you can cancel next month
MyFastRx
73/100Where the value is
- Publishes a full, specific price ladder (1/3/6/12-month) rather than a single vague 'starting at' figure
- LegitScript certified
- Flat pricing across all doses — no dosage upcharges as you titrate
The tradeoffs
- The true no-commitment monthly rate ($139 sema / $199 tirz) is meaningfully higher than the deep prepay-bundle rates the marketing emphasizes ($79-99 / $124-166) — those low numbers require paying for 3, 6, or 12 months upfront
- The lowest first-month price ($69 / $129) requires entering a promo code and applies to one month only
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.